Page last updated: 2024-08-21

amiloride and Weight Loss

amiloride has been researched along with Weight Loss in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antignac, C; Birn, H; Bistrup, C; Friis, UG; Hinrichs, GR; Jensen, BL; Lund, IK; Mollet, G; Nielsen, R; Svenningsen, P; Weyer, K1
Andersen, H; Bistrup, C; Hansen, PB; Henriksen, JE; Jensen, BL; Nielsen, F1
Broquist, M; Svedjeholm, R; Vánky, F1

Trials

1 trial(s) available for amiloride and Weight Loss

ArticleYear
Addition of a thiazide: an effective remedy for furosemide resistance after cardiac operations.
    The Annals of thoracic surgery, 1997, Volume: 63, Issue:4

    Topics: Administration, Oral; Aged; Amiloride; Coronary Artery Bypass; Creatinine; Diuretics; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Edema; Female; Furosemide; Heart Valve Diseases; Humans; Hydrochlorothiazide; Male; Postoperative Complications; Potassium Chloride; Weight Loss

1997

Other Studies

2 other study(ies) available for amiloride and Weight Loss

ArticleYear
Urokinase-type plasminogen activator contributes to amiloride-sensitive sodium retention in nephrotic range glomerular proteinuria in mice.
    Acta physiologica (Oxford, England), 2019, Volume: 227, Issue:4

    Topics: Amiloride; Animals; Epithelial Sodium Channel Blockers; Gene Expression Regulation; Intracellular Signaling Peptides and Proteins; Kidney Glomerulus; Membrane Proteins; Mice; Mice, Knockout; Nephrotic Syndrome; Peptide Hydrolases; Plasminogen; Proteinuria; Sodium; Urokinase-Type Plasminogen Activator; Water; Weight Loss

2019
Significant natriuretic and antihypertensive action of the epithelial sodium channel blocker amiloride in diabetic patients with and without nephropathy.
    Journal of hypertension, 2016, Volume: 34, Issue:8

    Topics: Albuminuria; Amiloride; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Epithelial Sodium Channel Blockers; Epithelial Sodium Channels; Female; Fibrinolysin; Humans; Kidney; Male; Middle Aged; Natriuresis; Plasminogen; Renin; Sodium; Sodium, Dietary; Weight Loss

2016